Literature DB >> 33925666

Correlation of Kidney Size on Computed Tomography with GFR, Creatinine and HbA1C for an Accurate Diagnosis of Patients with Diabetes and/or Chronic Kidney Disease.

Nashaat Ghaith1,2, Bassem Malaeb3, Rasha Itani1, Mohammed Alnafea4, Achraf Al Faraj1.   

Abstract

Diabetes is considered one of the major causes of chronic kidney disease (CKD), affecting renal blood vessels and nerves. Diagnosis of CKD by traditional biochemical serum and blood analyses is insufficient and insensitive, thus requiring the development of a more robust technique. This novel study aims to propose a new method for the accurate diagnosis of CKD, quantification of kidney damage, and its prognosis by physicians by measuring the kidney volume on computed tomography (CT). In total, 251 patients were enrolled in this retrospective study. They were divided into four groups: control, patients having diabetes, patients having CKD, and patients having both diabetes and CKD. Results showed that kidney volume correlated negatively with both GFR and HbA1C on CT images, in addition to decreasing faster in males than females. Moreover, HbA1C was shown to correlate positively with creatinine and negatively with GFR. Finally, GFR was more robust than creatinine when correlated with age. The association between kidney volume with GFR and HbA1c can be used to accurately anticipate kidney volume in established CKD on CT scan, especially in resource-poor settings. Furthermore, HbA1C can serve as a powerful biomarker for studying renal function in diabetic CKD patients as it correlates with creatinine and GFR.

Entities:  

Keywords:  HbA1c; albumin creatinine rate; chronic kidney disease; computed tomography; diabetes; glomerular filtration rate; kidney volume

Year:  2021        PMID: 33925666     DOI: 10.3390/diagnostics11050789

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  36 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  GFR as the "Gold Standard": Estimated, Measured, and True.

Authors:  Andrew S Levey; Lesley A Inker
Journal:  Am J Kidney Dis       Date:  2016-01       Impact factor: 8.860

3.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

Authors:  Michael Brownlee; Irl B Hirsch
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

4.  A simple method to estimate renal volume from computed tomography.

Authors:  Rodney H Breau; Edward Clark; Bryan Bruner; Patrick Cervini; Thomas Atwell; Greg Knoll; Bradley C Leibovich
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

5.  Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.

Authors:  Simone Gonçalves; Roberto Pecoits-Filho; Sônia Perreto; Silvio H Barberato; Andréa E M Stinghen; Emmanuel G A Lima; Roseana Fuerbringer; Sirlene M Sauthier; Miguel C Riella
Journal:  Nephrol Dial Transplant       Date:  2006-07-21       Impact factor: 5.992

Review 6.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

7.  Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Authors:  Matthew S Davenport; Mark A Perazella; Jerry Yee; Jonathan R Dillman; Derek Fine; Robert J McDonald; Roger A Rodby; Carolyn L Wang; Jeffrey C Weinreb
Journal:  Radiology       Date:  2020-01-21       Impact factor: 11.105

Review 8.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

Review 9.  Diabetic kidney diseases revisited: A new perspective for a new era.

Authors:  Haiyan Fu; Silvia Liu; Sheldon I Bastacky; Xiaojie Wang; Xiao-Jun Tian; Dong Zhou
Journal:  Mol Metab       Date:  2019-10-17       Impact factor: 7.422

10.  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.